{"pmid":32428291,"title":"Fever with Rash in COVID-19: Viral Exanthema or Secondary Lesions?","text":["Fever with Rash in COVID-19: Viral Exanthema or Secondary Lesions?","COVID-19 originated in Wuhan, China and has developed into a pandemic since late 2019. The virus possesses powerful pathogenicity as well as transmissibility. Many open questions remain, including the description of potential involvement of other organs than the respiratory tract. Most patients have mild influenza-like symptoms. A minority, especially patients with chronic lung disease, develops lethal disease including severe pneumonia, pulmonary edema, rapidly developing acute respiratory distress syndrome (ARDS), multiple organ failure and septic shock.","J Eur Acad Dermatol Venereol","Goldust, M","Abdelmaksoud, A","Shuang, Z","Xiang, C","Navarini, A A","32428291"],"abstract":["COVID-19 originated in Wuhan, China and has developed into a pandemic since late 2019. The virus possesses powerful pathogenicity as well as transmissibility. Many open questions remain, including the description of potential involvement of other organs than the respiratory tract. Most patients have mild influenza-like symptoms. A minority, especially patients with chronic lung disease, develops lethal disease including severe pneumonia, pulmonary edema, rapidly developing acute respiratory distress syndrome (ARDS), multiple organ failure and septic shock."],"journal":"J Eur Acad Dermatol Venereol","authors":["Goldust, M","Abdelmaksoud, A","Shuang, Z","Xiang, C","Navarini, A A"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32428291","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1111/jdv.16639","keywords":["covid-19","fever","rash","viral exanthema"],"locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Case Report"],"weight":1,"_version_":1667252837861556224,"score":9.490897,"similar":[{"pmid":32358895,"title":"Histological pattern in Covid-19 induced viral rash.","text":["Histological pattern in Covid-19 induced viral rash.","as stated by Estebanez et al(1) , incidence of dermatological affection in covid-19 patients may be different than reported until now. Datas and evidences are building up every day and we wanted to add a contribution describing the case of a 67-year-old patient, caucasian, with moderate obesity, a history of alcoholism and various chronic morbidities. No drug allergy was referred. She was sent to ER due to progressive dyspnoea and fever: after RT-PCR resulted positive to SARS-CoV 2, she was admitted to hospital and then intubated a week later due to worsening of the respiratory condition.","J Eur Acad Dermatol Venereol","Zengarini, Corrado","Orioni, Gionathan","Cascavilla, Alessandra","Horna Solera, Clara","Fulgaro, Ciro","Misciali, Cosimo","Patrizi, Annalisa","Gaspari, Valeria","32358895"],"abstract":["as stated by Estebanez et al(1) , incidence of dermatological affection in covid-19 patients may be different than reported until now. Datas and evidences are building up every day and we wanted to add a contribution describing the case of a 67-year-old patient, caucasian, with moderate obesity, a history of alcoholism and various chronic morbidities. No drug allergy was referred. She was sent to ER due to progressive dyspnoea and fever: after RT-PCR resulted positive to SARS-CoV 2, she was admitted to hospital and then intubated a week later due to worsening of the respiratory condition."],"journal":"J Eur Acad Dermatol Venereol","authors":["Zengarini, Corrado","Orioni, Gionathan","Cascavilla, Alessandra","Horna Solera, Clara","Fulgaro, Ciro","Misciali, Cosimo","Patrizi, Annalisa","Gaspari, Valeria"],"date":"2020-05-03T11:00:00Z","year":2020,"_id":"32358895","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1111/jdv.16569","keywords":["covid-19","rash","cutaneous","exanthema","histology","skin"],"topics":["Case Report"],"weight":1,"_version_":1666138495332122625,"score":170.17503},{"pmid":32330336,"title":"SARS-CoV-2 infection presenting as a febrile rash.","text":["SARS-CoV-2 infection presenting as a febrile rash.","The World Health Organization (WHO) has declared that Coronavirus disease 2019 (Covid-19) is a public health emergency of international concern as it continues to spread worldwide.(1) After a median incubation period of 4 days, fever and cough are the two most common manifestations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.","J Eur Acad Dermatol Venereol","Amatore, F","Macagno, N","Mailhe, M","Demarez, B","Gaudy-Marqueste, C","Grob, J J","Raoult, D","Brouqui, P","Richard, M A","32330336"],"abstract":["The World Health Organization (WHO) has declared that Coronavirus disease 2019 (Covid-19) is a public health emergency of international concern as it continues to spread worldwide.(1) After a median incubation period of 4 days, fever and cough are the two most common manifestations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection."],"journal":"J Eur Acad Dermatol Venereol","authors":["Amatore, F","Macagno, N","Mailhe, M","Demarez, B","Gaudy-Marqueste, C","Grob, J J","Raoult, D","Brouqui, P","Richard, M A"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32330336","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1111/jdv.16528","keywords":["covid-19","sars-cov-2","cutaneous manifestation","rash"],"topics":["Case Report"],"weight":1,"_version_":1666138494549884929,"score":168.21326},{"pmid":32307151,"pmcid":"PMC7161530","title":"Clinical Consensus Recommendations Regarding Non-Invasive Respiratory Support in the Adult Patient with Acute Respiratory Failure Secondary to SARS-CoV-2 infection.","text":["Clinical Consensus Recommendations Regarding Non-Invasive Respiratory Support in the Adult Patient with Acute Respiratory Failure Secondary to SARS-CoV-2 infection.","Coronavirus disease 2019 (COVID-19) is a respiratory tract infection caused by a newly emergent coronavirus, that was first recognized in Wuhan, China, in December 2019. Currently, the World Health Organization (WHO) has defined the infection as a global pandemic and there is a health and social emergency for the management of this new infection. While most people with COVID-19 develop only mild or uncomplicated illness, approximately 14% develop severe disease that requires hospitalization and oxygen support, and 5% require admission to an intensive care unit. In severe cases, COVID-19 can be complicated by the acute respiratory distress syndrome (ARDS), sepsis and septic shock, and multiorgan failure. This consensus document has been prepared on evidence-informed guidelines developed by a multidisciplinary panel of health care providers from four Spanish scientific societies (Spanish Society of Intensive Care Medicine [SEMICYUC], Spanish Society of Pulmonologists [SEPAR], Spanish Society of Emergency [SEMES], Spanish Society of Anesthesiology, Reanimation, and Pain [SEDAR]) with experience in the clinical management of patients with COVID-19 and other viral infections, including SARS, as well as sepsis and ARDS. The document provides clinical recommendations for the noninvasive respiratory support (noninvasive ventilation, high flow oxygen therapy with nasal cannula) in any patient with suspected or confirmed presentation of COVID-19 with acute respiratory failure. This consensus guidance should serve as a foundation for optimized supportive care to ensure the best possible chance for survival and to allow for reliable comparison of investigational therapeutic interventions as part of randomized controlled trials.","Rev Esp Anestesiol Reanim","Cinesi Gomez, C","Penuelas Rodriguez, O","Lujan Torne, M L","Egea Santaolalla, C","Masa Jimenez, J F","Garcia Fernandez, J","Carratala Perales, J M","Heili-Frades, S B","Ferrer Monreal, M","de Andres Nilsson, J M","Lista Arias, E","Sanchez Rocamora, J L","Garrote, J I","Zamorano Serrano, M J","Gonzalez Martinez, M","Farrero Munoz, E","Mediano San Andres, O","Rialp Cervera, G","Mas Serra, A","Hernandez Martinez, G","de Haro Lopez, C","Roca Gas, O","Ferrer Roca, R","Romero Berrocal, A","Ferrando Ortola, C","32307151"],"abstract":["Coronavirus disease 2019 (COVID-19) is a respiratory tract infection caused by a newly emergent coronavirus, that was first recognized in Wuhan, China, in December 2019. Currently, the World Health Organization (WHO) has defined the infection as a global pandemic and there is a health and social emergency for the management of this new infection. While most people with COVID-19 develop only mild or uncomplicated illness, approximately 14% develop severe disease that requires hospitalization and oxygen support, and 5% require admission to an intensive care unit. In severe cases, COVID-19 can be complicated by the acute respiratory distress syndrome (ARDS), sepsis and septic shock, and multiorgan failure. This consensus document has been prepared on evidence-informed guidelines developed by a multidisciplinary panel of health care providers from four Spanish scientific societies (Spanish Society of Intensive Care Medicine [SEMICYUC], Spanish Society of Pulmonologists [SEPAR], Spanish Society of Emergency [SEMES], Spanish Society of Anesthesiology, Reanimation, and Pain [SEDAR]) with experience in the clinical management of patients with COVID-19 and other viral infections, including SARS, as well as sepsis and ARDS. The document provides clinical recommendations for the noninvasive respiratory support (noninvasive ventilation, high flow oxygen therapy with nasal cannula) in any patient with suspected or confirmed presentation of COVID-19 with acute respiratory failure. This consensus guidance should serve as a foundation for optimized supportive care to ensure the best possible chance for survival and to allow for reliable comparison of investigational therapeutic interventions as part of randomized controlled trials."],"journal":"Rev Esp Anestesiol Reanim","authors":["Cinesi Gomez, C","Penuelas Rodriguez, O","Lujan Torne, M L","Egea Santaolalla, C","Masa Jimenez, J F","Garcia Fernandez, J","Carratala Perales, J M","Heili-Frades, S B","Ferrer Monreal, M","de Andres Nilsson, J M","Lista Arias, E","Sanchez Rocamora, J L","Garrote, J I","Zamorano Serrano, M J","Gonzalez Martinez, M","Farrero Munoz, E","Mediano San Andres, O","Rialp Cervera, G","Mas Serra, A","Hernandez Martinez, G","de Haro Lopez, C","Roca Gas, O","Ferrer Roca, R","Romero Berrocal, A","Ferrando Ortola, C"],"date":"2020-04-21T11:00:00Z","year":2020,"_id":"32307151","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.redar.2020.03.006","keywords":["aerosol-generating procedures","control de infeccion.","high-flow nasal therapy","infection control","non-invasive mechanical ventilation","procedimientos generadores de aerosoles","terapia nasal de alto flujo","ventilacion mecanica no invasiva"],"locations":["Wuhan","China","multiorgan","Spanish","Spanish","Spanish","Spanish","Spanish"],"countries":["China","Spain"],"countries_codes":["CHN|China","ESP|Spain"],"topics":["Treatment"],"weight":1,"_version_":1666138491176615936,"score":145.13646},{"pmid":32312600,"title":"Clinical consensus recommendations regarding non-invasive respiratory support in the adult patient with acute respiratory failure secondary to SARS-CoV-2 infection.","text":["Clinical consensus recommendations regarding non-invasive respiratory support in the adult patient with acute respiratory failure secondary to SARS-CoV-2 infection.","Coronavirus disease 2019 (COVID-19) is a respiratory tract infection caused by a newly emergent coronavirus, that was first recognized in Wuhan, China, in December 2019. Currently, the World Health Organization (WHO) has defined the infection as a global pandemic and there is a health and social emergency for the management of this new infection. While most people with COVID-19 develop only mild or uncomplicated illness, approximately 14% develop severe disease that requires hospitalization and oxygen support, and 5% require admission to an intensive care unit. In severe cases, COVID-19 can be complicated by the acute respiratory distress syndrome (ARDS), sepsis and septic shock, and multiorgan failure. This consensus document has been prepared on evidence-informed guidelines developed by a multidisciplinary panel of health care providers from four Spanish scientific societies (Spanish Society of Intensive Care Medicine [SEMICYUC], Spanish Society of Pulmonologists [SEPAR], Spanish Society of Emergency [SEMES], Spanish Society of Anesthesiology, Reanimation, and Pain [SEDAR]) with experience in the clinical management of patients with COVID-19 and other viral infections, including SARS, as well as sepsis and ARDS. The document provides clinical recommendations for the noninvasive respiratory support (noninvasive ventilation, high flow oxygen therapy with nasal cannula) in any patient with suspected or confirmed presentation of COVID-19 with acute respiratory failure. This consensus guidance should serve as a foundation for optimized supportive care to ensure the best possible chance for survival and to allow for reliable comparison of investigational therapeutic interventions as part of randomized controlled trials.","Med Intensiva","Cinesi Gomez, Cesar","Penuelas Rodriguez, Oscar","Lujan Torne, Manel","Egea Santaolalla, Carlos","Masa Jimenez, Juan Fernando","Garcia Fernandez, Javier","Carratala Perales, Jose Manuel","Heili-Frades, Sarah Beatrice","Ferrer Monreal, Miquel","de Andres Nilsson, Jose M","Lista Arias, Eva","Sanchez Rocamora, Juan Luis","Garrote, Jose Ignacio","Zamorano Serrano, Miguel J","Gonzalez Martinez, Monica","Farrero Munoz, Eva","Mediano San Andres, Olga","Rialp Cervera, Gemma","Mas Serra, Arantxa","Hernandez Martinez, Gonzalo","de Haro Lopez, Candelaria","Roca Gas, Oriol","Ferrer Roca, Ricard","Romero Berrocal, Antonio","Ferrando Ortola, Carlos","32312600"],"abstract":["Coronavirus disease 2019 (COVID-19) is a respiratory tract infection caused by a newly emergent coronavirus, that was first recognized in Wuhan, China, in December 2019. Currently, the World Health Organization (WHO) has defined the infection as a global pandemic and there is a health and social emergency for the management of this new infection. While most people with COVID-19 develop only mild or uncomplicated illness, approximately 14% develop severe disease that requires hospitalization and oxygen support, and 5% require admission to an intensive care unit. In severe cases, COVID-19 can be complicated by the acute respiratory distress syndrome (ARDS), sepsis and septic shock, and multiorgan failure. This consensus document has been prepared on evidence-informed guidelines developed by a multidisciplinary panel of health care providers from four Spanish scientific societies (Spanish Society of Intensive Care Medicine [SEMICYUC], Spanish Society of Pulmonologists [SEPAR], Spanish Society of Emergency [SEMES], Spanish Society of Anesthesiology, Reanimation, and Pain [SEDAR]) with experience in the clinical management of patients with COVID-19 and other viral infections, including SARS, as well as sepsis and ARDS. The document provides clinical recommendations for the noninvasive respiratory support (noninvasive ventilation, high flow oxygen therapy with nasal cannula) in any patient with suspected or confirmed presentation of COVID-19 with acute respiratory failure. This consensus guidance should serve as a foundation for optimized supportive care to ensure the best possible chance for survival and to allow for reliable comparison of investigational therapeutic interventions as part of randomized controlled trials."],"journal":"Med Intensiva","authors":["Cinesi Gomez, Cesar","Penuelas Rodriguez, Oscar","Lujan Torne, Manel","Egea Santaolalla, Carlos","Masa Jimenez, Juan Fernando","Garcia Fernandez, Javier","Carratala Perales, Jose Manuel","Heili-Frades, Sarah Beatrice","Ferrer Monreal, Miquel","de Andres Nilsson, Jose M","Lista Arias, Eva","Sanchez Rocamora, Juan Luis","Garrote, Jose Ignacio","Zamorano Serrano, Miguel J","Gonzalez Martinez, Monica","Farrero Munoz, Eva","Mediano San Andres, Olga","Rialp Cervera, Gemma","Mas Serra, Arantxa","Hernandez Martinez, Gonzalo","de Haro Lopez, Candelaria","Roca Gas, Oriol","Ferrer Roca, Ricard","Romero Berrocal, Antonio","Ferrando Ortola, Carlos"],"date":"2020-04-22T11:00:00Z","year":2020,"_id":"32312600","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.medin.2020.03.005","keywords":["aerosol-generating procedures","control de infeccion","high-flow nasal therapy","infection control","non-invasive mechanical ventilation","procedimientos generadores de aerosoles","terapia nasal de alto flujo","ventilacion mecanica no invasiva"],"locations":["Wuhan","China","multiorgan","Spanish","Spanish","Spanish","Spanish","Spanish"],"countries":["China","Spain"],"countries_codes":["CHN|China","ESP|Spain"],"topics":["Treatment"],"weight":1,"_version_":1666138493449928705,"score":145.13646},{"pmid":32336563,"title":"Clinical Consensus Recommendations Regarding Non-Invasive Respiratory Support in the Adult Patient with Acute Respiratory Failure Secondary to SARS-CoV-2 infection.","text":["Clinical Consensus Recommendations Regarding Non-Invasive Respiratory Support in the Adult Patient with Acute Respiratory Failure Secondary to SARS-CoV-2 infection.","Coronavirus disease 2019 (COVID-19) is a respiratory tract infection caused by a newly emergent coronavirus, that was first recognized in Wuhan, China, in December 2019. Currently, the World Health Organization (WHO) has defined the infection as a global pandemic and there is a health and social emergency for the management of this new infection. While most people with COVID-19 develop only mild or uncomplicated illness, approximately 14% develop severe disease that requires hospitalization and oxygen support, and 5% require admission to an intensive care unit. In severe cases, COVID-19 can be complicated by the acute respiratory distress syndrome (ARDS), sepsis and septic shock, and multiorgan failure. This consensus document has been prepared on evidence-informed guidelines developed by a multidisciplinary panel of health care providers from four Spanish scientific societies (Spanish Society of Intensive Care Medicine [SEMICYUC], Spanish Society of Pulmonologists [SEPAR], Spanish Society of Emergency [SEMES], Spanish Society of Anesthesiology, Reanimation, and Pain [SEDAR]) with experience in the clinical management of patients with COVID-19 and other viral infections, including SARS, as well as sepsis and ARDS. The document provides clinical recommendations for the noninvasive respiratory support (noninvasive ventilation, high flow oxygen therapy with nasal cannula) in any patient with suspected or confirmed presentation of COVID-19 with acute respiratory failure. This consensus guidance should serve as a foundation for optimized supportive care to ensure the best possible chance for survival and to allow for reliable comparison of investigational therapeutic interventions as part of randomized controlled trials.","Arch Bronconeumol","Cinesi Gomez, Cesar","Penuelas Rodriguez, Oscar","Lujan Torne, Manel","Egea Santaolalla, Carlos","Masa Jimenez, Juan Fernando","Garcia Fernandez, Javier","Carratala Perales, Jose Manuel","Heili-Frades, Sarah Beatrice","Ferrer Monreal, Miquel","de Andres Nilsson, Jose M","Lista Arias, Eva","Sanchez Rocamora, Juan Luis","Garrote, Jose Ignacio","Zamorano Serrano, Miguel J","Gonzalez Martinez, Monica","Farrero Munoz, Eva","Mediano San Andres, Olga","Rialp Cervera, Gemma","Mas Serra, Arantxa","Hernandez Martinez, Gonzalo","de Haro Lopez, Candelaria","Roca Gas, Oriol","Ferrer Roca, Ricard","Romero Berrocal, Antonio","Ferrando Ortola, Carlos","32336563"],"abstract":["Coronavirus disease 2019 (COVID-19) is a respiratory tract infection caused by a newly emergent coronavirus, that was first recognized in Wuhan, China, in December 2019. Currently, the World Health Organization (WHO) has defined the infection as a global pandemic and there is a health and social emergency for the management of this new infection. While most people with COVID-19 develop only mild or uncomplicated illness, approximately 14% develop severe disease that requires hospitalization and oxygen support, and 5% require admission to an intensive care unit. In severe cases, COVID-19 can be complicated by the acute respiratory distress syndrome (ARDS), sepsis and septic shock, and multiorgan failure. This consensus document has been prepared on evidence-informed guidelines developed by a multidisciplinary panel of health care providers from four Spanish scientific societies (Spanish Society of Intensive Care Medicine [SEMICYUC], Spanish Society of Pulmonologists [SEPAR], Spanish Society of Emergency [SEMES], Spanish Society of Anesthesiology, Reanimation, and Pain [SEDAR]) with experience in the clinical management of patients with COVID-19 and other viral infections, including SARS, as well as sepsis and ARDS. The document provides clinical recommendations for the noninvasive respiratory support (noninvasive ventilation, high flow oxygen therapy with nasal cannula) in any patient with suspected or confirmed presentation of COVID-19 with acute respiratory failure. This consensus guidance should serve as a foundation for optimized supportive care to ensure the best possible chance for survival and to allow for reliable comparison of investigational therapeutic interventions as part of randomized controlled trials."],"journal":"Arch Bronconeumol","authors":["Cinesi Gomez, Cesar","Penuelas Rodriguez, Oscar","Lujan Torne, Manel","Egea Santaolalla, Carlos","Masa Jimenez, Juan Fernando","Garcia Fernandez, Javier","Carratala Perales, Jose Manuel","Heili-Frades, Sarah Beatrice","Ferrer Monreal, Miquel","de Andres Nilsson, Jose M","Lista Arias, Eva","Sanchez Rocamora, Juan Luis","Garrote, Jose Ignacio","Zamorano Serrano, Miguel J","Gonzalez Martinez, Monica","Farrero Munoz, Eva","Mediano San Andres, Olga","Rialp Cervera, Gemma","Mas Serra, Arantxa","Hernandez Martinez, Gonzalo","de Haro Lopez, Candelaria","Roca Gas, Oriol","Ferrer Roca, Ricard","Romero Berrocal, Antonio","Ferrando Ortola, Carlos"],"date":"2020-04-28T11:00:00Z","year":2020,"_id":"32336563","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1016/j.arbres.2020.03.005","keywords":["aerosol-generating procedures","control de infeccion","high-flow nasal therapy","infection control","non-invasive mechanical ventilation","procedimientos generadores de aerosoles","terapia nasal de alto flujo","ventilacion mecanica no invasiva"],"locations":["Wuhan","China","multiorgan","Spanish","Spanish","Spanish","Spanish","Spanish"],"countries":["China","Spain"],"countries_codes":["CHN|China","ESP|Spain"],"topics":["Treatment"],"weight":1,"_version_":1666138494176591872,"score":145.13646}]}